BioPharma Dive - Latest News

Lilly expands US manufacturing build-out with $50B target

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry to reshore drug production.

Feb 26, 2025 - 15:37
 0
Lilly expands US manufacturing build-out with $50B target

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry to reshore drug production.

Read More

Tags:

Previous Article

With plan to build 4 new plants, Eli Lilly doubles down on US drug manufacturing

Next Article

STAT+: Eli Lilly announces $27 billion investment in U.S. drug manufacturing sites

Related Posts

Partnering for success in early phase clinical development

Partnering for success in early phase clinical development

Feb 24, 2025  0

Immune drugmakers Alumis and Acelyrin to merge

Immune drugmakers Alumis and Acelyrin to merge

Feb 9, 2025  0

Axsome secures top drug’s future with Teva patent settlement

Axsome secures top drug’s future with Teva patent settl...

Feb 10, 2025  0